首页 | 本学科首页   官方微博 | 高级检索  
     

树突状细胞肿瘤疫苗的制备及临床应用面临的问题
引用本文:俞志勇,陈虎,冯凯. 树突状细胞肿瘤疫苗的制备及临床应用面临的问题[J]. 中国实验血液学杂志, 2004, 12(3): 397-400
作者姓名:俞志勇  陈虎  冯凯
作者单位:军事医学科学院附属医院造血干细胞移植科,北京,100039
摘    要:
树突状细胞(DC)是目前发现的功能最强的抗原呈递细胞,其在肿瘤免疫临床治疗中的应用受到越来越多的关注。目前,通过各种方法提取肿瘤抗原来冲击致敏DC,再将已培养成熟的DC回输到病人体内,以激发机体产生明确的抗肿瘤免疫应答,已成为有效的临床抗肿瘤治疗手段,也为肿瘤临床继手术切除、放化疗及其它综合治疗后又开辟了一个新的治疗途径。本文就DC的生物学特性、体外培养及其临床应用作一综述。

关 键 词:树突状细胞 肿瘤疫苗 免疫递呈细胞 细胞毒性淋巴细胞
文章编号:1009-2137(2004)03-0397-04
修稿时间:2003-04-28

Preparation of Dendritic Cell Tumor-Vaccine with Dendritic Cells and Problems in Its Clinical Uses —— Review
YU Zhi-Yong,CHEN Hu,FENG Kai Hematopoietic Stem Cell Transplatation Center,Affiliated Hospital of Academy of Military Medical Sciences,Beijing ,China. Preparation of Dendritic Cell Tumor-Vaccine with Dendritic Cells and Problems in Its Clinical Uses —— Review[J]. Journal of experimental hematology, 2004, 12(3): 397-400
Authors:YU Zhi-Yong  CHEN Hu  FENG Kai Hematopoietic Stem Cell Transplatation Center  Affiliated Hospital of Academy of Military Medical Sciences  Beijing   China
Affiliation:Hematopoietic Stem Cell Transplatation Center, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100039, China.
Abstract:
Dendritic cell (DC),the most powerful antigen presenting cell,has been paid close attention to tumor immunotherapy. The tumor antigens were extracted by different ways to pulse DC,and then the muture DC were infused to patients to accelerate anti-tumor immuno responses. Its clinical use would provide a new therapeutic pathway other than surgical operation,irradiation,chemotherapy. In this paper,biological characteristics of DC,tumor-vaccine preparation and its clinical use were reviewed.
Keywords:dendritic cell  antigen presenting cell  tumor  cytotoxic T cell
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号